Cigna Group $CI Shares Sold by Munich Reinsurance Co Stock Corp in Munich

Munich Reinsurance Co Stock Corp in Munich reduced its position in shares of Cigna Group (NYSE:CI) by 59.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,536 shares of the health services provider’s stock after selling 22,418 shares during the period. Munich Reinsurance Co Stock Corp in Munich’s holdings in Cigna Group were worth $4,283,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. GQG Partners LLC purchased a new stake in Cigna Group in the second quarter valued at $1,628,918,000. Norges Bank purchased a new stake in Cigna Group in the 4th quarter valued at about $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its stake in Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after buying an additional 3,141,844 shares during the period. Bank of America Corp DE acquired a new stake in shares of Cigna Group during the second quarter valued at about $827,692,000. Finally, Legal & General Group Plc purchased a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $542,779,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $282.24 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 0.98 and a beta of 0.31. The stock’s 50-day moving average is $283.51 and its two-hundred day moving average is $281.07. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Piper Sandler lowered their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Mizuho raised their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Finally, Sanford C. Bernstein raised their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $339.45.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 23,012 shares of company stock worth $6,386,550 in the last three months. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.